Jasper A J Smits1, Michael J Zvolensky, Michelle L Davis, David Rosenfield, Bess H Marcus, Timothy S Church, Mark B Powers, Georita M Frierson, Michael W Otto, Lindsey B Hopkins, Richard A Brown, Scarlett O Baird. 1. From the Department of Psychology and Institute for Mental Health Research (Smits, Davis, Powers, Baird), The University of Texas at Austin, Austin, Texas; Department of Psychology (Zvolensky), University of Houston, Houston, Texas; Department of Behavioral Science (Zvolensky), The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Psychology (Rosenfield), Southern Methodist University, Dallas, Texas; Department of Family & Preventive Medicine (Marcus), University of California at San Diego, San Diego, California; Pennington Biomedical Research Center (Church), Louisiana State University, Baton Rouge, Louisiana; Department of Psychology (Frierson), Howard University, Washington, DC; Departments of Psychology and Psychological and Brain Sciences (Otto), Boston University, Boston, Massachusetts; Stress and Health Research Program (Hopkins), San Francisco VA Medical Center, San Francisco, California; and School of Nursing (Brown), The University of Texas at Austin, Austin, Texas.
Abstract
OBJECTIVES: High anxiety sensitivity predicts poor smoking cessation outcomes. Aerobic exercise reduces anxiety sensitivity and aspects of the risk conferred by anxiety sensitivity. In the current study, we examined whether exercise can aid smoking cessation in adults with high anxiety sensitivity. METHODS:Participants were sedentary and low-activity adult daily smokers (n = 136) with elevated prescreen anxiety sensitivity. Participants received 15 weeks of standard smoking cessation treatment (ST; cognitive behavioral therapy plus nicotine replacement therapy). In addition, participants were simultaneously randomized to 15 weeks of either an exercise intervention (ST + EX; n = 72) or a wellness education control condition (ST + CTRL; n = 64). Self-reported smoking abstinence was assessed weekly during the intervention, at the end of treatment (10 weeks after the target quit date), and at 4 and 6 months after the target quit date. Abstinence was verified by expired carbon monoxide readings and saliva cotinine. RESULTS: Results indicated that point prevalence abstinence (PPA) and prolonged abstinence (PA) rates were significantly higher for ST + EX than for ST + CTRL at each of the major end points among persons with high anxiety sensitivity (PPA: b = -0.91, standard error [SE] = 0.393, t(1171) = -2.33, p = .020; PA: b = -0.98, SE = 0.346, t(132) = -2.84, p = .005), but not among those with low anxiety sensitivity (PPA: b = -0.23, SE = 0.218, t(1171) = -1.06, p = .29; PA: b = -0.31, SE = 0.306, t(132) = -1.01, p = .32). CONCLUSIONS: The present results suggest that exercise facilitates the odds of quit success for smokers with high levels of anxiety sensitivity and therefore may be a useful therapeutic tactic for this high-risk segment of the smoking population. TRIAL REGISTRATION: ClinicalTrials.gov, NCT01065506.
RCT Entities:
OBJECTIVES:High anxiety sensitivity predicts poor smoking cessation outcomes. Aerobic exercise reduces anxiety sensitivity and aspects of the risk conferred by anxiety sensitivity. In the current study, we examined whether exercise can aid smoking cessation in adults with high anxiety sensitivity. METHODS:Participants were sedentary and low-activity adult daily smokers (n = 136) with elevated prescreen anxiety sensitivity. Participants received 15 weeks of standard smoking cessation treatment (ST; cognitive behavioral therapy plus nicotine replacement therapy). In addition, participants were simultaneously randomized to 15 weeks of either an exercise intervention (ST + EX; n = 72) or a wellness education control condition (ST + CTRL; n = 64). Self-reported smoking abstinence was assessed weekly during the intervention, at the end of treatment (10 weeks after the target quit date), and at 4 and 6 months after the target quit date. Abstinence was verified by expired carbon monoxide readings and saliva cotinine. RESULTS: Results indicated that point prevalence abstinence (PPA) and prolonged abstinence (PA) rates were significantly higher for ST + EX than for ST + CTRL at each of the major end points among persons with high anxiety sensitivity (PPA: b = -0.91, standard error [SE] = 0.393, t(1171) = -2.33, p = .020; PA: b = -0.98, SE = 0.346, t(132) = -2.84, p = .005), but not among those with low anxiety sensitivity (PPA: b = -0.23, SE = 0.218, t(1171) = -1.06, p = .29; PA: b = -0.31, SE = 0.306, t(132) = -1.01, p = .32). CONCLUSIONS: The present results suggest that exercise facilitates the odds of quit success for smokers with high levels of anxiety sensitivity and therefore may be a useful therapeutic tactic for this high-risk segment of the smoking population. TRIAL REGISTRATION: ClinicalTrials.gov, NCT01065506.
Authors: Michael J Zvolensky; Anka A Vujanovic; Marcel O Bonn Miller; Amit Bernstein; Andrew R Yartz; Kristin L Gregor; Alison C McLeish; Erin C Marshall; Laura E Gibson Journal: Nicotine Tob Res Date: 2007-09 Impact factor: 4.244
Authors: Nicholas P Allan; Amanda M Raines; Daniel W Capron; Aaron M Norr; Michael J Zvolensky; Norman B Schmidt Journal: J Anxiety Disord Date: 2014-07-19
Authors: Jessica A Whiteley; David M Williams; Shira Dunsiger; Ernestine G Jennings; Joseph T Ciccolo; Beth C Bock; Anna Albrecht; Alfred Parisi; Sarah E Linke; Bess H Marcus Journal: Am J Prev Med Date: 2012-09 Impact factor: 5.043
Authors: Sanjat Kanjilal; Edward W Gregg; Yiling J Cheng; Ping Zhang; David E Nelson; George Mensah; Gloria L A Beckles Journal: Arch Intern Med Date: 2006-11-27
Authors: Richard A Brown; Ana M Abrantes; Haruka Minami; Jennifer P Read; Bess H Marcus; John M Jakicic; David R Strong; Mary Ella Dubreuil; Alan A Gordon; Susan E Ramsey; Christopher W Kahler; Gregory L Stuart Journal: J Subst Abuse Treat Date: 2014-03-01
Authors: Michael J Zvolensky; David Rosenfield; Lorra Garey; Brooke Y Kauffman; Kirsten J Langdon; Mark B Powers; Michael W Otto; Michelle L Davis; Bess H Marcus; Timothy S Church; Georita M Frierson; Lindsey B Hopkins; Daniel J Paulus; Scarlett O Baird; Jasper A J Smits Journal: Health Psychol Date: 2018-04-30 Impact factor: 4.267
Authors: Charles Philip Brandt; Jafar Bakhshaie; Charles Jardin; Chad Lemaire; Brooke Y Kauffman; Carla Sharp; Michael J Zvolensky Journal: Int J Behav Med Date: 2017-02
Authors: Jolene Jacquart; Santiago Papini; Michelle L Davis; David Rosenfield; Mark B Powers; Georita M Frierson; Lindsey B Hopkins; Scarlett O Baird; Bess H Marcus; Timothy S Church; Michael W Otto; Michael J Zvolensky; Jasper A J Smits Journal: Drug Alcohol Depend Date: 2017-03-06 Impact factor: 4.492
Authors: Ana M Abrantes; Samantha G Farris; Haruka Minami; David R Strong; Deborah Riebe; Richard A Brown Journal: Nicotine Tob Res Date: 2018-04-02 Impact factor: 4.244
Authors: Jafar Bakhshaie; Paulina A Kulesz; Lorra Garey; Kirsten J Langdon; Michael S Businelle; Adam M Leventhal; Matthew W Gallagher; Norman B Schmidt; Kara Manning; Renee Goodwin; Michael J Zvolensky Journal: J Consult Clin Psychol Date: 2017-11-27
Authors: Lorra Garey; Brooke Y Kauffman; Kara F Manning; Samar A Taha; Norman B Schmidt; Clayton Neighbors; Michael J Zvolensky Journal: J Addict Med Date: 2019 Jan/Feb Impact factor: 3.702
Authors: Mark B Powers; Brooke Y Kauffman; Anne L Kleinsasser; Eunjung Lee-Furman; Jasper A J Smits; Michael J Zvolensky; David Rosenfield Journal: Contemp Clin Trials Date: 2016-08-25 Impact factor: 2.226
Authors: Jasper A J Smits; Mark B Powers; David Rosenfield; Michael J Zvolensky; Jolene Jacquart; Michelle L Davis; Christopher G Beevers; Bess H Marcus; Timothy S Church; Michael W Otto Journal: Ment Health Phys Act Date: 2016-03